Synairgen to raise £6.4 million in share placing
This article was originally published in Scrip
Executive Summary
Synairgen, a respiratory drug discovery company, hopes to raise £6.35 million by placing around 37.4 million of its new ordinary shares at a price of 17 pence per share.